What question did this study set out to answer?

The aim is to evaluate the economic burden of prostate cancer from both direct and indirect cost perspectives.

February 9, 2026PharmacoEconomicsOpen Access

A Systematic Review of the Economic Burden of Prostate Cancer: Direct and Indirect Cost Perspectives

View Full Paper

Ask AI

Bookmark

Authors

A systematic review reveals high economic costs of prostate cancer, suggesting early detection and equitable access can mitigate expenses.

The aim is to evaluate the economic burden of prostate cancer from both direct and indirect cost perspectives.
Conducted a systematic review of existing literature on prostate cancer costs.
Analyzed economic impacts associated with various stages of the disease.
Examined effects of early detection and treatment approaches.
Prostate cancer imposes significant costs on healthcare systems, especially in advanced stages.
Early detection and equitable access may reduce these economic burdens.
Emerging diagnostics and minimally invasive interventions could further influence cost outcomes.

Darbà et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

A systematic review reveals high economic costs of prostate cancer, suggesting early detection and equitable access can mitigate expenses.